Market Overview:
The global drug-device combination products market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in drug-device combination products. Based on type, the infusion pumps segment is expected to account for the largest share of the global drug-device combination products market in 2018. This segment is also projected to grow at a high CAGR during the forecast period. Factors such as technological advancements and growing demand for minimally invasive surgeries are contributing to the growth of this segment. Based on application, hospitals are expected to account for the largest share of the global drug-device combination products market in 2018.
Product Definition:
A drug–device combination product is a product that combines a drug with one or more medical devices. The term usually refers to products that combine drugs and medical devices into a single unit, such as an injection pen for insulin. Drug-device combinations may also refer to products in which the active pharmaceutical ingredient (API) is delivered by a medical device, such as an inhaler or transdermal patch.
Infusion Pumps:
Infusion pumps are medical devices used to transfer a controlled amount of fluid from one container to another. They are widely used in hospital settings for various applications such as chemotherapy, dialysis, and hydration therapy among others.
The infusion pumps market is expected to grow at a lucrative rate during the forecast period owing to factors such as increasing geriatric population base coupled with rising incidences of chronic diseases requiring long term care.
Orthopedic Combination Products:
Orthopedic combination products are a group of drugs and devices that are used to treat musculoskeletal disorders. The global orthopedic combination products and it's usage in drug-device combination product market size was valued at USD 1,2018 million in 2016. It is expected to grow at a CAGR of XX% during the forecast period.
Application Insights:
Based on application, the global market is segmented into hospital, clinic and other. The hospital segment dominated the overall market in terms of revenue in 2017. This can be attributed to factors such as increasing prevalence of chronic diseases and growing aging population that require medical attention. Furthermore, rising investments by governments for developing healthcare infrastructure are further driving the growth of this segment.
The other category includes home healthcare devices and equipment as well as non-clinical applications such as drug delivery systems for pain management or recreational drugs used for euphoria generation among others which are expected to grow at a significant rate over the forecast period due to increased R&D initiatives undertaken by various companies including Pfizer Inc., Johnson & Johnson, Merck KGaA., Amgen Inc., Astrazeneca LP., Novartis AG etc.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of global players, high healthcare expenditure, and favorable reimbursement policies & regulatory reforms. The Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing government initiatives for improving healthcare infrastructure and adoption of advanced technologies coupled with growing awareness about drug safety & efficacy in clinical use. Moreover, rising prevalence of chronic diseases such as cancer and diabetes will drive regional market growth during the forecast period. In addition, an increase in preference for generic drugs due to patent expirations or new entry by original manufacturers is also anticipated to boost this region’s development over the coming years (Figure 1).
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. The incidence of chronic diseases such as cancer, diabetes, and heart disease is on the rise, which is driving the demand for drug–device combination products.
- Technological advancements: Drug–device combination products are becoming increasingly popular due to the technological advancements in this field. Newer and more advanced devices are being developed that can be used in conjunction with drugs to provide better treatment outcomes for patients. This is helping to drive market growth significantly.
- Rising healthcare expenditure: Healthcare expenditure around the world has been rising steadily in recent years due to increased awareness about health issues and rising incomes among people across different regions. This has led to an increase in demand for better and more expensive medical treatments, including drug–device combination products therapies..
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug–Device Combination Products Market Research Report
By Type
Infusion Pumps, Orthopedic Combination Products, Photodynamic Therapy Devices, Transdermal Patches, Drug Eluting Stents, Wound Care Products, Inhalers, Other
By Application
Hospital, Clinic, Other
By Companies
Abbott, Terumo Corporation, Stryker Corporation, Mylan, Medtronic, Allergan, Boston Scientific, Novartis, BD, Teleflex Incorporated, Abbott
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
180
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Drug–Device Combination Products Market Report Segments:
The global Drug–Device Combination Products market is segmented on the basis of:
Types
Infusion Pumps, Orthopedic Combination Products, Photodynamic Therapy Devices, Transdermal Patches, Drug Eluting Stents, Wound Care Products, Inhalers, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Terumo Corporation
- Stryker Corporation
- Mylan
- Medtronic
- Allergan
- Boston Scientific
- Novartis
- BD
- Teleflex Incorporated
- Abbott
Highlights of The Drug–Device Combination Products Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Infusion Pumps
- Orthopedic Combination Products
- Photodynamic Therapy Devices
- Transdermal Patches
- Drug Eluting Stents
- Wound Care Products
- Inhalers
- Other
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug–Device Combination Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug–Device combination products are a type of medical device that combine two or more medical devices. These products can help improve the effectiveness and safety of treatments by combining different types of devices into one product.
Some of the key players operating in the drug–device combination products market are Abbott, Terumo Corporation, Stryker Corporation, Mylan, Medtronic, Allergan, Boston Scientific, Novartis, BD, Teleflex Incorporated, Abbott.
The drug¢‚¬€œdevice combination products market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Drug–Device Combination Products Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Drug–Device Combination Products Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Drug–Device Combination Products Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Drug–Device Combination Products Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Drug–Device Combination Products Market Size & Forecast, 2020-2028
4.5.1 Drug–Device Combination Products Market Size and Y-o-Y Growth
4.5.2 Drug–Device Combination Products Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Infusion Pumps
5.2.2 Orthopedic Combination Products
5.2.3 Photodynamic Therapy Devices
5.2.4 Transdermal Patches
5.2.5 Drug Eluting Stents
5.2.6 Wound Care Products
5.2.7 Inhalers
5.2.8 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Drug–Device Combination Products Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Drug–Device Combination Products Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Infusion Pumps
9.6.2 Orthopedic Combination Products
9.6.3 Photodynamic Therapy Devices
9.6.4 Transdermal Patches
9.6.5 Drug Eluting Stents
9.6.6 Wound Care Products
9.6.7 Inhalers
9.6.8 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Infusion Pumps
10.6.2 Orthopedic Combination Products
10.6.3 Photodynamic Therapy Devices
10.6.4 Transdermal Patches
10.6.5 Drug Eluting Stents
10.6.6 Wound Care Products
10.6.7 Inhalers
10.6.8 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Infusion Pumps
11.6.2 Orthopedic Combination Products
11.6.3 Photodynamic Therapy Devices
11.6.4 Transdermal Patches
11.6.5 Drug Eluting Stents
11.6.6 Wound Care Products
11.6.7 Inhalers
11.6.8 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Infusion Pumps
12.6.2 Orthopedic Combination Products
12.6.3 Photodynamic Therapy Devices
12.6.4 Transdermal Patches
12.6.5 Drug Eluting Stents
12.6.6 Wound Care Products
12.6.7 Inhalers
12.6.8 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Infusion Pumps
13.6.2 Orthopedic Combination Products
13.6.3 Photodynamic Therapy Devices
13.6.4 Transdermal Patches
13.6.5 Drug Eluting Stents
13.6.6 Wound Care Products
13.6.7 Inhalers
13.6.8 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Drug–Device Combination Products Market: Competitive Dashboard
14.2 Global Drug–Device Combination Products Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Terumo Corporation
14.3.3 Stryker Corporation
14.3.4 Mylan
14.3.5 Medtronic
14.3.6 Allergan
14.3.7 Boston Scientific
14.3.8 Novartis
14.3.9 BD
14.3.10 Teleflex Incorporated
14.3.11 Abbott
